← All organizations

Nordic Myeloma Study Group

Academic/HospitalWebsite ↗

Also known as: NMSG | NMSG (Nordic Myeloma Study Group) | Nordic Myeloma Study Group | Nordic Myeloma Study Group, Germany

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 31, 2025

Timeline

1980s

Jun 1, 1987
Nordic Myeloma Study Group— Founded

Drugs by trial phase (16 distinct, 12 trials)

Phase 3 (7 own, 0 via acquisition)

Phase 2 (9 own, 0 via acquisition)

Indications

Studied for

Recent trials (14)

NCT07107529CollaboratorPhase 2Oct 31, 2025
NCT04939844CollaboratorPhase 2Jun 29, 2021
NCT03376672CollaboratorPhase 2May 31, 2018
NCT03314636CollaboratorPhase 2Mar 16, 2018
NCT02572492CollaboratorPhase 2Jan 1, 2015
NCT01208766CollaboratorPhase 3Jan 1, 2011
NCT00602511Lead sponsorPhase 3Oct 1, 2007
NCT00508209Lead sponsorPhase 2Jul 1, 2007
NCT00417911Lead sponsorPhase 3Dec 1, 2005
NCT00417911Overall official - principal investigatorPhase 3Dec 1, 2005
NCT00382694Lead sponsorPhase 2May 1, 2005
NCT00218855CollaboratorPhase 3Jan 1, 2002
NCT00376883Overall official - principal investigatorPhase 3Jan 1, 2000
NCT00376883Lead sponsorPhase 3Jan 1, 2000

Details

Founded: Oslo, NO Jun 1, 1987
Last known activity: Oct 31, 2025